Type 2 Diabetes

A real, if modest, effect across a large evidence base

Type 2 diabetes is closely tied to gut bacteria composition, with certain bacterial imbalances linked to worse insulin resistance and inflammation. A large meta-analysis pooling 68 trial comparisons across 58 studies, covering 3,835 people, found that probiotic, prebiotic, or synbiotic supplementation produced statistically significant reductions in fasting plasma glucose, HbA1c, the standard 3-month blood sugar marker, and fasting insulin, compared with placebo.

Source: Meta-analysis of randomized controlled trials of the effects of probiotics on type 2 diabetes in adults

A consistent bacterial signature across many studies

A systematic review pulling together the available research on gut bacteria in type 2 diabetes found a consistent pattern across studies: Escherichia-Shigella, a bacterial group linked to inflammation, was repeatedly found at higher levels in people with type 2 diabetes, while Faecalibacterium prausnitzii, a bacterium that produces the beneficial compound butyrate, showed up consistently as protective, at lower levels in people with the condition. The review's authors were honest that these are observational findings that can't establish which comes first, the bacterial imbalance or the diabetes itself, but the sheer consistency of this specific pattern across many separate studies makes it a genuinely strong association rather than a one-off finding.

Source: A systematic review on gut microbiota in type 2 diabetes mellitus

A specific trial as an add-on to standard medication

A 12-week randomised, double-blind trial tested a specific strain, Bifidobacterium longum subsp. longum BL21, added to metformin, the standard first-line diabetes medication, against metformin plus placebo. The added probiotic group showed a significant further reduction in HbA1c, with a non-significant trend toward improved fasting glucose and insulin resistance too, an honest, proportionate result rather than an overstated one.

Source: Probiotic Supplementation With Bifidobacterium longum Subsp. Longum BL21 Improves Glycemic Control and Modulates Gut Microbiota in Type 2 Diabetes

As with any probiotic, these effects depend on the bacteria being properly fed. A strain added to diabetes treatment still needs fibre and plant compounds to establish itself well enough to keep producing a meaningful, ongoing effect on blood sugar control.

A specific mechanism: short-chain fatty acids and a gut hormone

Part of the reason fibre-fed gut bacteria help with blood sugar comes down to a specific chain of events. When bacteria ferment fibre, they produce short-chain fatty acids, including one called butyrate, which trigger gut cells to release a hormone called GLP-1. GLP-1 slows digestion, increases the feeling of fullness, and prompts the pancreas to release insulin more effectively, directly supporting better blood sugar control. A study measuring these short-chain fatty acids directly in the blood of 160 people, some of whom underwent detailed insulin-sensitivity testing, found that higher circulating levels of these compounds were linked to better insulin sensitivity and higher GLP-1 levels, a genuinely mechanistic link measured in real people rather than inferred from animal models alone.

This mechanism helps explain why fibre itself, not just probiotic capsules, shows real effects. An 8-week randomised trial gave people with type 2 diabetes 10.5g of soluble psyllium fibre daily and found fasting blood sugar dropped from 163 to 119 mg/dL, HbA1c fell from 8.5% to 7.5%, and HOMA-IR, a marker of insulin resistance, fell from 11.3 to 5.8, a striking set of improvements from fibre alone, without any added probiotic strain. Researchers behind the wider body of probiotic trial evidence are honest that the reductions seen with probiotic strains specifically are more modest than this, of real but limited clinical significance on their own, meaning probiotics work best as a genuine complement to standard treatment and to fibre itself, rather than a replacement for either.

Source: Circulating but not faecal short-chain fatty acids are related to insulin sensitivity, lipolysis and GLP-1 concentrations in humans

Source: Soluble fibers from psyllium improve glycemic response and body weight among diabetes type 2 patients

What this means for you

Type 2 diabetes needs proper diagnosis and ongoing management, including monitoring and medication as prescribed by a doctor, since untreated or poorly controlled diabetes carries serious long-term risks. Given the genuine, consistent trial evidence above, a specific probiotic strain is a reasonable, low-risk addition to discuss with a doctor alongside standard treatment. A varied, plant-rich diet supports the same gut bacteria this research ties to better blood sugar control. That's the same idea behind GutLab, everyday gut health starts with regularly feeding the microbiome a broad range of plant-rich ingredients.